Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: A case-control study

References

• Tsubono Y, Hisamichi S. Screening for gastric cancer in Japan. Gastric Cancer 2000; 3: 9–18
   PubMedGoogle Scholar
• Oshima A, Hirata N, Ubukata T, Umeda T, Fujimoto I. Evaluation of a mass screening program for stomach cancer with a case control study design. Int J Cancer 1986; 38: 829–33
   PubMed Web of Science ®Google Scholar
• Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takano A. The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study. Int J Cancer 1995; 60: 45–8
   PubMed Web of Science ®Google Scholar
• Abe Y, Mitsushima T, Nagatani K, Ikuma H. Minamihira Y. Epidemiological evaluation of the protective effect for dying of stomach cancer by screening program for stomach cancer with applying a method of case-control study: a study of an efficient screening program for stomach cancer. J Jpn Soc Gastroenterol 1995;92:836–45 (in Japanese with English abstract).
   PubMedGoogle Scholar
• Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer 2006; 118: 2315–21
   PubMed Web of Science ®Google Scholar
• Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204–9
   PubMed Web of Science ®Google Scholar
• Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22: 133–41
   PubMedGoogle Scholar
• Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003; 38: 332–8
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Am J Gastroenterol 1996; 91: 959–62
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ozasa K, Higashi A, Hayashi K, Mizuno S, Mukai M, et al. Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan. J Clin Gastroenterol 1997; 25: 391–4
   PubMed Web of Science ®Google Scholar
• Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(Suppl 1)S37–43
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Eng J Med 2001; 345: 784–9
   PubMed Web of Science ®Google Scholar
• Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Tanaka S, et al. K-ras mutation in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002; 97: 562–6
   PubMed Web of Science ®Google Scholar
• Hiyama T, Tanaka S, Shima H, Kose K, Kitadai Y, Ito M, et al. Somatic mutation of mitochondrial DNA in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Mol Med 2003; 12: 169–74
   PubMed Web of Science ®Google Scholar
• Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol 1998; 93: 1090–6
   PubMed Web of Science ®Google Scholar
• Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993; 84: 1086–90
   PubMedGoogle Scholar
• Hattori Y, Tashiro H, Kawamoto T, Kodama Y. Sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens. Jpn J Cancer Res 1995; 86: 1210–5
   PubMedGoogle Scholar
• Kodoi A, Yoshihara M, Sumii K, Haruma K, Kajiyama G. Serum pepsinogen in screening for gastric cancer. J Gastroenterol 1995; 30: 452–60
   PubMed Web of Science ®Google Scholar
• Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Tanaka S, et al. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Hiroshima J Med Sci 1997; 46: 81–6
   PubMedGoogle Scholar
• Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44: 693–7
   PubMed Web of Science ®Google Scholar
• Miki K, Morita M, Sasajima M, Hoshino R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003; 98: 735–9
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereica A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11: 141–7
   PubMed Web of Science ®Google Scholar
• Ogawa H, Kato I, Tominaga S. Family history of cancer among cancer patients. Jpn J Cancer Res 1985; 76: 113–8
   PubMedGoogle Scholar
• Nouraie M, Pietinen P, Kamangar F, Dawsey SM, Abnet CC, Albanes D, et al. Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers. Cancer Epidemiol Biomarkers Prev 2005; 14: 2087–92
   PubMed Web of Science ®Google Scholar
• Yoshihara M, Sumii K, Haruma K. Gastric mass survey with measurement of serum pepsinogen levels in a local area. Situation and practical method of the pepsinogen method in a local area. J Gastroenterol Mass Survey 1996;34:325–30 (in Japanese with English abstract).
   Google Scholar
• Xie XF, Ito M, Yoshihara M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen levels in the Japanese population: prospective study of 9 years of follow up. Hepatogastroenterology. In press.
   Google Scholar